skip to main content, skip to Quick links, or skip to Search

main content



The enrollment period for this trial has ended.

Immunolight Therapy for Cancer in Dogs


The goal of this study is to evaluate the safety of Immunolight therapy in canine cancer patients. Information gathered in this study will be used to
tell us more about how this therapy can be effectively used for treatment of various solid malignancies in dogs and people.


Tumor examples include:

Study Benefits Include:


Clinical Studies Core at 919.515.2633 or or NCSU Radiation Oncology Service at 919.513.6690 or


Page last updated September 18, 2014